HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elise Lepeltier Selected Research

ferrocifen

5/2021Ferrocifen Loaded Lipid Nanocapsules: A Promising Anticancer Medication against Multidrug Resistant Tumors.
2/2021Corrigendum to "p722 ferrocifen loaded lipid nanocapsules improve survival of murine xenografted-melanoma via a potentiation of apoptosis and an activation of CD8+ T lymphocytes" [Int. J. Pharm. 593 (2021) 120111].
1/2021p722 ferrocifen loaded lipid nanocapsules improve survival of murine xenografted-melanoma via a potentiation of apoptosis and an activation of CD8+ T lymphocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elise Lepeltier Research Topics

Disease

10Neoplasms (Cancer)
05/2021 - 06/2011
7Melanoma (Melanoma, Malignant)
05/2021 - 07/2013
2Glioblastoma (Glioblastoma Multiforme)
05/2021 - 07/2018
2Carcinoma (Carcinomatosis)
07/2013 - 01/2013
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2021
1Leukemia
12/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2021
1Breast Neoplasms (Breast Cancer)
05/2021
1Rheumatoid Arthritis
01/2021
1Arthritis (Polyarthritis)
01/2021
1Schistosomiasis (Bilharziasis)
11/2020
1Communicable Diseases (Infectious Diseases)
10/2016
1Venous Thromboembolism
11/2014
1Drug-Related Side Effects and Adverse Reactions
05/2014
1Cardiotoxicity
01/2014
1Pancreatic Neoplasms (Pancreatic Cancer)
07/2013
1Adenocarcinoma
07/2013
1Body Weight (Weight, Body)
01/2013
1Papillary Thyroid Cancer
06/2011

Drug/Important Bio-Agent (IBA)

8LipidsIBA
05/2021 - 06/2011
6NanocapsulesIBA
05/2021 - 07/2018
5Pharmaceutical PreparationsIBA
11/2020 - 01/2013
4ProdrugsIBA
01/2020 - 01/2013
3ferrocifenIBA
05/2021 - 01/2021
2CytidineIBA
12/2021 - 06/2014
2Small Interfering RNA (siRNA)IBA
08/2019 - 06/2011
2Biological ProductsIBA
10/2016 - 07/2013
2SqualeneIBA
06/2014 - 06/2011
2GemcitabineFDA Link
06/2014 - 07/2013
1Azacitidine (5 Azacytidine)FDA Link
12/2021
1N-vinyl-2-pyrrolidinoneIBA
04/2021
1imidazoleIBA
04/2021
1CurcuminIBA
01/2021
1OxamniquineFDA Link
11/2020
1GoldIBA
01/2020
1Antineoplastic Agents (Antineoplastics)IBA
01/2020
11,2-distearoylphosphatidylethanolamine (DSPE)IBA
08/2019
1DesminIBA
03/2019
1Peptides (Polypeptides)IBA
07/2018
1Starch (Cornstarch)IBA
10/2016
1NucleotidesIBA
10/2016
12',3'-dideoxyguanosine 5'-triphosphateIBA
10/2016
1Triethylenephosphoramide (TEPA)IBA
10/2016
1Terpenes (Terpenoids)IBA
06/2014
1PolymersIBA
05/2014
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2014
1isopreneIBA
07/2013
1nasIBA
07/2013
1Oncogene Proteins (Oncogene Protein)IBA
06/2011

Therapy/Procedure

5Therapeutics
05/2021 - 07/2013
2Intravenous Injections
07/2018 - 06/2011
1Subcutaneous Injections
03/2019
1Oral Administration
11/2014
1Aftercare (After-Treatment)
07/2013